Navigation Links
Phase 3 Topical Drug for Raynaud's Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
Date:12/13/2012

tary topical delivery system in late-stage clinical trials targeting infectious and inflammatory skin diseases and conditions. The Company's major efforts have been focused on projects targeting Raynaud's phenomenon, nail psoriasis and actinic keratosis. In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the 'Safe Harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the Company's current expectation or forecasts of future events. MediQuest's performance and financial results could differ materially from those reflected in these forward-looking statements due to the decisions of regulatory authorities, ability to implement its commercial plans, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries generally. For a discussion of these and other risks and uncertainties that may affect the forward-looking statements please contact the Company. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. MediQuest undertakes no obligation to update publicly any forward-looking statement
www.mqti.com

Contact information
Joseph K. Piper
Managing Director, Point B Capital
jpiper@pointbcap.com
206-577-7223

Media Contact: Siavash Forootan MediQuest Therapeutics, 215-238-8881, sforootan@numodacapital.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediQuest Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
2. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
3. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
4. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
5. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
6. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
7. uniQure Initiates Phase I in Acute Intermittent Porphyria
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- Research and Markets  has announced the addition of ... their offering. Global Market Report of Pralmorelin ... and regionally ( Europe , Asia ... Latin America etc.). It captures Pralmorelin market trends, ... on three primary areas; manufacture methods & technology development, market ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: Global Coatings for Medical Devices ... This report analyzes the worldwide markets ... by the following Product Segments: Active Coatings, Protective ... provides separate comprehensive analytics for the US, ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today ... diagnostic platform during a special event at the company,s ... , on September 5, 2014. The event, which will ... the ApolloDx website, www.apollodx.com .    ... testing," said Jared Bauer , Co-Founder and Managing ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
(Date:8/21/2014)... OpsAssure, the local start-up offering ... participate in the Harbor Accelerator's 14 week development ... and valuable resources.he Harbor’s goal is to launch ... start-up selected for the program receives a variety ... businesses grow quickly, test markets and become viable ...
(Date:8/21/2014)... August 21, 2014 Recently nominated as the ... quite the journey to be the man he is today. ... always had a positive look on women, respecting them as professionals ... owes gratefulness and thanks to a man who he had the ... Howard Stern. , KC Armstrong’s name will ring a bell to ...
(Date:8/21/2014)... BambooIndustry.com, one of the most famous bamboo product suppliers ... hand scraped bamboo floorings to its online ... offer for these elegant items. According to the company’s ... up to 25% off; the promotion will come to ... looks and available in different varieties, the company’s new ...
(Date:8/20/2014)... Top 10 Best SEO Hosting ... and announced Bluehost ( http://www.bluehost.com/track/seohosts ), MaxCDN, and ... provide high quality PHP hosting at affordable rates. ... SEO Hosting are unbiased and entirely independent, ensuring ... possible. During the recent years, web hosting industry ...
(Date:8/20/2014)... August 21, 2014 On September 7th, 2014 ... MS organization connects people living with MS with people who ... dollars and are 85% of the way to their goal. ... registration begins at 11:30 and the walk starts at ... available to answer question about chiropractic care and how it ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2
... released today the American College of Physicians reaffirmed its ... on Price and Clinical Performance Information, the first paper ... an introduction and overview of the issues and challenges ... that increasing transparency in the health care system can ...
... University of Utah determined that the 2009 pandemic influenza ... in children than the seasonal flu. The most ... details of the study, the most extensive evaluation of ... in the September issue of Annals of Neurology ...
... An international consortium of scientists has discovered new ... affect the risk of ovarian cancer in the general ... online in Nature Genetics . The consortium, ... based the new work on their earlier research comparing ...
... accurately locate breast cancers, reduce the need for second ... spheres of silica, a porous glass, can mark the ... ultrasound imaging in the operating room. A ... of California, San Diego, created the new material, which ...
... The drug pazopanib may help revolutionize the care ... researchers at Mayo Clinic who are publishing findings ... Lancet Oncology . VIDEO ALERT: Additional audio ... Keith Bible describing the research, are available on the ...
... of Kevin Foskett, PhD, the Isaac Ott Professor of Physiology ... a possible new target for fighting cystic fibrosis (CF) that ... in affected CF-related cells. Their finding appears in the ... role of CFTR, the chloride ion channel mutated in CF ...
Cached Medicine News:Health News:Benefits of increased health care transparency hinge on reliable and valid information, says ACP 2Health News:Benefits of increased health care transparency hinge on reliable and valid information, says ACP 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2Health News:2 studies find new genetic links to ovarian cancer risk 2Health News:2 studies find new genetic links to ovarian cancer risk 3Health News:Better marker for breast cancer may reduce need for second surgeries 2Health News:Targeted therapy decreases progression rate in thyroid cancer 2Health News:Channeling efforts to fight cystic fibrosis 2
... frames are designed with the safety and comfort ... Schott RS-520 (also called SF-6) leaded glass, the ... meet standards, as set for optical clarity, visible ... our eyewear is protecting your eyes, it also ...
... Both lenses and frames are designed with ... mind. Our lenses are Schott RS-520 (also called ... shielding glass. These lenses meet standards, as set ... prism correction. ,While our eyewear is protecting ...
... frames are designed with the safety and comfort ... Schott RS-520 (also called SF-6) leaded glass, the ... meet standards, as set for optical clarity, visible ... our eyewear is protecting your eyes, it also ...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
Medicine Products: